Thiotepa bulk supplier for pharma manufacturers

Thiotepa 15 mg, 100 mg Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 15 mg, 100 mg

Reference Brands: Thioplex (USA/EU) , Tepylute (USA)

Thiotepa is a Oncology Cancer Care product available as Injection in strengths 15 mg, 100 mg. It corresponds to the reference brands Thioplex (USA/EU) , Tepylute (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Thiotepa? List it or send an offer →

Product Description:

Thiotepa is a chemotherapy medication classified as an alkylating agent, sold under the brand name Tepadina and other regional brands. It works by directly damaging the DNA of rapidly dividing cells, preventing cell replication and ultimately leading to cell death. This mechanism makes thiotepa effective against a variety of cancers, including breast cancer, ovarian cancer, bladder cancer, and hematologic malignancies.

As an alkylating agent, thiotepa interferes with the normal function of cancer cell DNA, disrupting their ability to grow and multiply. It is used in clinical settings for systemic therapy as well as in conditioning regimens prior to bone marrow or stem cell transplantation. Thiotepa’s targeted cytotoxic action provides an important option for treating malignancies that are responsive to DNA-alkylating chemotherapy, and its use is carefully monitored due to potential side effects associated with chemotherapy agents.

Thiotepa — third party manufacturing & bulk supply

Thiotepa 15 mg, 100 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Thiotepa is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Thiotepa listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Thiotepa →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Thiotepa is used to treat various cancers including breast, ovarian, and bladder cancers, as well as for pre-transplant conditioning in hematopoietic stem cell transplantation.

Thiotepa is a synthetic alkylating agent that interferes with DNA replication and RNA transcription in rapidly dividing cancer cells.

The trade name of thiotepa is Thioplex.

Thiotepa (Thioplex) is manufactured by Bristol-Myers Squibb and other licensed pharmaceutical manufacturers in various regions.

The generic name is thiotepa.

The brand name is Thioplex.

Thiotepa injections are produced in GMP-certified facilities by licensed pharmaceutical companies, including Bristol-Myers Squibb, for global distribution.